Figure 1.
Establishment and verification of the new method and characterization of stability of ghrelin-aAb in serum. (A) A detection assay was designed, consisting of a secreted alkaline phosphatase (SEAP) in frame to human ghrelin as one fusion protein, to be used as bait for the autoantibodies (Y-symbol, ghrelin-specific immunoglobulin highlighted in red) that become enriched by protein A-mediated immunoprecipitation. Detection is achieved by incubation with a chemiluminescent substrate (CSPD), and relative light units (RLU) are recorded by a luminometer. After the establishment of stable clones expressing SEAP-ghrelin fusion protein, the signal detection method and certain matrix characteristics were characterized. (B) Increasing signal strength (RLU) was observed with increasing amount of commercial anti-ghrelin antibody in the new assay, supporting its general suitability to detect and quantify ghrelin-aAb. (B) Signal stability of positive samples was tested by incubation for 5 days and 10 days at room temperature or 4°C. The comparison to the initial signal strength indicates high stability of ghrelin-aAb in serum under these conditions.